SDF-1 expression and tumor-infiltrating lymphocytes identify clinical subtypes of triple-negative breast cancer with different responses to neoadjuvant chemotherapy and survival

SDF-1 expression and tumor-infiltrating lymphocytes identify clinical subtypes of triple-negative breast cancer with different responses to neoadjuvant chemotherapy and survival

BackgroundIn this study, we investigated the prediction and prognostic value of SDF-1 for triple-negative breast cancer (TNBC) patients who underwent neoadjuvant chemotherapy (NAC) following standard radical surgery.MethodsA total of 303 TNBC patients were included in this study. The NAC regimen was...

Full description

Bibliographic Details
Main Authors: Ruo-Xi Wang, Peng Ji, Yue Gong, Zhi-Ming Shao, Sheng Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Immunology
Subjects:
breast cancer
neoadjuvant chemotherapy
SDF-1
TILs
pathological complete response
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.940635/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.940635/full

Similar Items